CAMBRIDGE, England, & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary ...
Phase 1 data of first-in-class NBD1 stabilizers, SION-719 and SION-451, demonstrated they were generally well tolerated and exceeded desired ...
Paired DNA and RNA sequencing is an increasingly popular method used to produce libraries from FFPE samples. Whilst traditional sequencing methods can present challenges distinguishing between the two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback